Latest Bare-metal stent Stories
The second generation drug-eluting stent Xience V performs well in patients having primary PCI for ST elevation myocardial infarction, and has a better safety profile than that of bare metal stents.
Limiting use of drug-eluting stents to a selected group of patients is cost efficient and did not increase risk of death or heart attack within a year.
TEL AVIV, Israel, Aug. 16, 2011 /PRNewswire/ -- InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard(TM) mesh protective stent system, today announced that it has filed its Form 10-Q for the three months ended June 30, 2011 with the U.S.
DURHAM, N.C., July 26, 2011 /PRNewswire/ -- Micell Technologies, Inc. today announced that it has completed patient enrollment in its DESSOLVE II CE Mark clinical study of the MiStentÂ® Drug-Eluting Coronary Stent System.
DURHAM, N.C., June 29, 2011 /PRNewswire/ -- Micell Technologies, Inc.
Trial shows that use of bivalirudin alone improves survival in heart-attack patients compared to heparin and a glycoprotein IIb/IIIa inhibitor; drug-eluting stents are also shown to be more effective than bare-metal stents, with equivalent safety.
MOUNTAIN VIEW, Calif., May 17, 2011 /PRNewswire/ -- AccessClosure, Inc., the market segment leader in extravascular closure devices, announced today an exclusive agreement with Biosensors International for the distribution of the Mynx(TM) Vascular Closure Device throughout the United Kingdom, Switzerland and France.
DURHAM, N.C., May 11, 2011 /PRNewswire/ -- Micell Technologies, Inc.
NATICK, Mass., April 25, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S.
- A handkerchief.
- Specifically— The legendary sweat-cloth; the handkerchief of St. Veronica, according to tradition miraculously impressed with the mask of Christ; also, the napkin about Christ's head (Johu xx. 7).
- In general, any miraculous portrait of Christ.